How has been the historical performance of EP Biocomposites?

Answer:The historical performance of EP Biocomposites shows a progressive increase in net sales and profitability over the years, with notable fluctuations in certain metrics. Breakdown: EP Biocomposites has demonstrated a steady growth in net sales, rising from 2.95 Cr in Mar'21 to 12.01 Cr in Mar'25. The total operating income followed a similar trend, increasing from 2.95 Cr in Mar'21 to 12.01 Cr in Mar'25. However, the raw material costs also escalated, reaching 7.98 Cr in Mar'25 from 1.79 Cr in Mar'21. Operating profit, excluding other income, improved from 0.46 Cr in Mar'21 to 1.78 Cr in Mar'25, while the overall operating profit, including other income, increased from 0.46 Cr to 1.89 Cr in the same period. Profit before tax peaked at 1.42 Cr in Mar'25, although it slightly declined from 1.57 Cr in Mar'24. Profit after tax also saw growth, reaching 1.03 Cr in Mar'25 compared to 0.36 Cr in Mar'21. The company's total assets increased significantly from 0.55 Cr in Mar'20 to 16.61 Cr in Mar'25, alongside total liabilities which rose from 0.55 Cr to 16.61 Cr. Cash flow from operating activities remained stagnant at 0.00 Cr in Mar'25, while cash and cash equivalents at the end of the period were stable at 1.00 Cr. Overall, EP Biocomposites has shown resilience and growth in its financial performance over the years, despite some fluctuations in profit margins and cash flow.